Detalles de la búsqueda
1.
A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study.
BMC Cancer
; 24(1): 436, 2024 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38589856
2.
Variant allele frequency in baseline circulating tumour DNA to measure tumour burden and to stratify outcomes in patients with RAS wild-type metastatic colorectal cancer: a translational objective of the Valentino study.
Br J Cancer
; 126(3): 449-455, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34811502
3.
The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs.
J Transl Med
; 20(1): 371, 2022 08 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35974365
4.
Investigating the concordance in molecular subtypes of primary colorectal tumors and their matched synchronous liver metastasis.
Int J Cancer
; 147(8): 2303-2315, 2020 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32270478
5.
Prognostic and Predictive Value of Microsatellite Instability, Inflammatory Reaction and PD-L1 in Gastric Cancer Patients Treated with Either Adjuvant 5-FU/LV or Sequential FOLFIRI Followed by Cisplatin and Docetaxel: A Translational Analysis from the ITACA-S Trial.
Oncologist
; 25(3): e460-e468, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32162808
6.
Is a pharmacogenomic panel useful to estimate the risk of oxaliplatin-related neurotoxicity in colorectal cancer patients?
Pharmacogenomics J
; 19(5): 465-472, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30713338
7.
Correction to: A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY tract cancers (BTC) at high risk for recurrence: PURITY study.
BMC Cancer
; 24(1): 563, 2024 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38711003
8.
Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer.
Br J Cancer
; 117(3): 347-352, 2017 Jul 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-28654634
9.
Development of a Protocol for Single-Cell Analysis of Circulating Tumor Cells in Patients with Solid Tumors.
Adv Exp Med Biol
; 994: 83-103, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28560669
10.
Serum soluble urokinase-type plasminogen activator receptor as a serum marker of inflammatory response that leads to tissue damage and surgical complication.
Wound Repair Regen
; 24(6): 1036-1040, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27759946
11.
Osteopontin, E-cadherin, and ß-catenin expression as prognostic biomarkers in patients with radically resected gastric cancer.
Gastric Cancer
; 19(2): 412-420, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25862567
12.
Circulating tumor cells as a longitudinal biomarker in patients with advanced chemorefractory, RAS-BRAF wild-type colorectal cancer receiving cetuximab or panitumumab.
Int J Cancer
; 137(6): 1467-74, 2015 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25704501
13.
DPD and UGT1A1 deficiency in colorectal cancer patients receiving triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan.
Br J Clin Pharmacol
; 80(3): 581-8, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25782327
14.
Undetected toxicity risk in pharmacogenetic testing for dihydropyrimidine dehydrogenase.
Int J Mol Sci
; 16(4): 8884-95, 2015 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-25906475
15.
Effect of 10-day broccoli consumption on inflammatory status of young healthy smokers.
Int J Food Sci Nutr
; 65(1): 106-11, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23992556
16.
The pan-immune-inflammation value is associated with clinical outcomes in patients with advanced TNBC treated with first-line, platinum-based chemotherapy: an institutional retrospective analysis.
Ther Adv Med Oncol
; 15: 17588359231165978, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37063779
17.
Transcriptomic Signatures of MSI-High Metastatic Colorectal Cancer Predict Efficacy of Immune Checkpoint Inhibitors.
Clin Cancer Res
; 29(18): 3771-3778, 2023 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37439810
18.
Circulating Fatty Acid Profile as a Biomarker for Immunotherapy in Advanced Non-Small Cell Lung Cancer.
Clin Lung Cancer
; 23(7): e489-e499, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35948460
19.
ALK Inhibitors in Patients With ALK Fusion-Positive GI Cancers: An International Data Set and a Molecular Case Series.
JCO Precis Oncol
; 6: e2200015, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35476549
20.
Circulating Tumor DNA as a Marker of Minimal Residual Disease After Radical Resection of Colorectal Liver Metastases.
JCO Precis Oncol
; 6: e2200244, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36356286